Abstract
CRASH (Corticosteroid randomisation after significant head injury) is a prospective multi-centre randomised double blind study of methylprednisolone versus placebo in mild, moderate and severe head injury. Patients are eligible up to 8 hours from injury. To date the CRASH trial has recruited 9000 patients. The trial is recruiting from 200 hospitals in 50 countries with another 100 centres planning to join the trial. The target for recruitment is 20,000 patients by 2006. The trial is wholly funded by the Medical Research Council of Great Britain and is multidisciplinary, involving doctors and nurses from a range of specialities. A recent systematic review of corticosteroids in head injury demonstrated a risk of death in the corticosteroid treated group 2% lower than in the control group. The 95% confidence interval ranges from a 6% lower mortality to a 2% higher mortality. This result is compatible with there being no real benefit, but it is also compatible with there being a small benefit of a few percent. An improvement in mortality of 2% would theoretically save 10,000 lives per 500,000 patients treated. The global impact of such a treatment effect would be significant as the number of head injuries world-wide continues to rise.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alderson P, Roberts I (1997) Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ 314: 1855–1859
Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskins DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J (1990) A randomised, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. New Engl J Med 322(20): 1405–1411
Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings MG, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W (1998) Methylprednisolone or tirilizad mesylate admnistration after acute spinal cord injury: 1-year follow up. Results of the third national acute spinal cord injury randomised controled trial. J Neurosurg 89(5): 699–706
Bullock R, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, Newell DW, Pitts LH, Rosner MJ, Wilberger JW (1996) Guidelines for the Management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med 3(2): 109–127
Crimmins DW, Palmer JD (2000) Snapshot view of emergency neurosurgical head injury care in Great Britain and Ireland. J Neurol Neurosurgery Psychiatry 68: 8–13
Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH (1995) Survey of critical care management of comatose head injured patients in the United States. Crit Care Med 23(3): 560–567
Giannotta SL, Weiss MH, Apuzzo MLJ, Martin E (1984) High dose glucocorticoids in the management of severe head injury. Neurosurgery 15:497–501
Hall ED (1985) High dose glucocorticoid treatment improves neurological recovery in head injured mice. J Neurosurg 62: 882–887
Jeevaratnam DR, Menon DK (1996) Survey of intensive care of severely head injured patients in the United Kingdom. BMJ 312: 944–947
Murray CJL, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498–1504
Stubbs DF, Stiger TR, Harris WR (1989) Multinational controlled trial of high-dose Methylprednisolone in moderately severe head injury. In: Capildeo R (ed) Steroids in diseases of the central nervous system. John Wiley & Sons, Chichester, pp 163–168
Yates D, Roberts I (2000) Corticosteroids in head injury. It’s time for a large simple randomised trial. CRASH trial management group. Corticosteroid randomisation after significant head injury. (Editorial) BMJ 321(7254): 128–129
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Wien
About this paper
Cite this paper
Wasserberg, J. (2004). The MRC CRASH trial — a large, simple randomised trial of steroids in head injury. In: Baethmann, A., Eriskat, J., Lehmberg, J., Plesnila, N. (eds) Mechanisms of Secondary Brain Damage from Trauma and Ischemia. Acta Neurochirurgica Supplements, vol 89. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0603-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0603-7_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7206-3
Online ISBN: 978-3-7091-0603-7
eBook Packages: Springer Book Archive